BCL2L1 and neoplasm: As expected, although the single inhibition of BCLXL (by sgBCLXL) or MCL1 (by MCL1 inhibitor) did not affect the growth of HGC-27 xenografts, co-targeting BCLXL and MCL1 led to a substantial suppression of tumor growth in vivo (Fig. 2G).